Pulmonary atresia-intact ventricular septum syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1208OMIM:265150Q22.6
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pulmonary atresia with intact ventricular septum (PA-IVS) is a rare congenital heart defect present at birth in which the pulmonary valve fails to form properly, resulting in complete obstruction of blood flow from the right ventricle to the pulmonary artery. Unlike pulmonary atresia with a ventricular septal defect, the ventricular septum remains intact, meaning there is no hole between the two lower chambers of the heart. This condition critically impairs the heart's ability to send blood to the lungs for oxygenation. Survival after birth depends on the persistence of fetal circulatory pathways, particularly the patent ductus arteriosus (PDA), which allows some blood to reach the lungs. Without intervention, closure of the PDA leads to severe cyanosis (bluish discoloration of the skin due to low oxygen levels) and is life-threatening. The right ventricle in PA-IVS is often underdeveloped (hypoplastic), though its size can vary considerably among affected individuals. In some cases, abnormal connections between the right ventricle and the coronary arteries (sinusoidal communications or coronary fistulae) develop, which can make the coronary circulation dependent on the right ventricle — a feature known as right ventricle-dependent coronary circulation (RVDCC). This is a critical consideration in treatment planning because decompressing the right ventricle in such cases could compromise coronary blood flow and lead to myocardial ischemia. Other associated findings may include tricuspid valve abnormalities, right atrial enlargement, and an atrial septal defect or patent foramen ovale that allows right-to-left shunting. Immediate treatment after birth typically involves administration of prostaglandin E1 to maintain ductal patency, followed by surgical or catheter-based interventions. Treatment strategies depend on the anatomy and include radiofrequency perforation or surgical valvotomy of the pulmonary valve, creation of a systemic-to-pulmonary artery shunt (such as a modified Blalock-Taussig shunt), or staged single-ventricle palliation culminating in a Fontan procedure for patients with severely hypoplastic right ventricles. Some patients with adequate right ventricular size may ultimately achieve a biventricular repair. Long-term outcomes have improved significantly with advances in neonatal cardiac surgery and interventional cardiology, though lifelong cardiac follow-up is required.

Clinical phenotype terms— hover any for plain English:

Abnormal tricuspid valve morphologyHP:0001702Pulmonary artery atresiaHP:0004935Maternal diabetesHP:0009800
Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Pulmonary atresia-intact ventricular septum syndrome.

View clinical trials →

No actively recruiting trials found for Pulmonary atresia-intact ventricular septum syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pulmonary atresia-intact ventricular septum syndrome community →

No specialists are currently listed for Pulmonary atresia-intact ventricular septum syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pulmonary atresia-intact ventricular septum syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pulmonary atresia-intact ventricular septum syndromeForum →

No community posts yet. Be the first to share your experience with Pulmonary atresia-intact ventricular septum syndrome.

Start the conversation →

Latest news about Pulmonary atresia-intact ventricular septum syndrome

No recent news articles for Pulmonary atresia-intact ventricular septum syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pulmonary atresia-intact ventricular septum syndrome

What is Pulmonary atresia-intact ventricular septum syndrome?

Pulmonary atresia with intact ventricular septum (PA-IVS) is a rare congenital heart defect present at birth in which the pulmonary valve fails to form properly, resulting in complete obstruction of blood flow from the right ventricle to the pulmonary artery. Unlike pulmonary atresia with a ventricular septal defect, the ventricular septum remains intact, meaning there is no hole between the two lower chambers of the heart. This condition critically impairs the heart's ability to send blood to the lungs for oxygenation. Survival after birth depends on the persistence of fetal circulatory pathw

How is Pulmonary atresia-intact ventricular septum syndrome inherited?

Pulmonary atresia-intact ventricular septum syndrome follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Pulmonary atresia-intact ventricular septum syndrome typically begin?

Typical onset of Pulmonary atresia-intact ventricular septum syndrome is neonatal. Age of onset can vary across affected individuals.